13 February 2020

Recently 45 Postdocs and PhD candidates attended the first Interactive career day organized by Janssen Pharmaceutica, to learn more about career perspectives and R&D activities that may lead to ideas and potential future collaboration on a longer term. 

12 Participants were selected to showcase their research in a 3-minute pitch. All other participants were invited to present a poster. A jury selected the 3 best pitches and 3 best posters. These researchers will be invited to have an individual session with Janssen Pharmaceutica. 

Winners pitches:
  • Marilen Benner: Healthy uterus, healthy placenta, healthy offspring
  • Jeroen Slaat: Tumor cells.
  • Kinga Matula: Single-cell detection of metastatic cancer

Winners posters:
  • Michael Teders et al.: The Energy-Transfer-Enabled Biocompatible Disulfide-Ene Reaction
  • Mike Marvin Ruth, Jodie Schilkraut et al.: A hollow-fiber infection model supported drug discovery pipeline for antmycobacterial drugs
  • Elena Daines, Peer van Duppen: Chemical reaction networks in a dynamic environment


 

Related news items


Terrestrial bacteria can grow on nutrients from space

26 May 2020

Researchers from the Radboudumc describe in an article in Astrobiology that bacteria can survive on an 'extraterrestrial diet', which affected their pathogenic potential.

read more

The new front line: big data podcast

22 May 2020

What role do big data and technology play in the fight against corona? What data can help save lives? How do you ensure that your personal health data is used safely? Among others, Peter-Bram 't Hoen explains.

read more

OARSI Basic Science Award for Peter van der Kraan

22 May 2020

Purpose of this Basic Science Award of the Osteoarthritis Research Society International (OARSI) is to stimulate fundamental research in the field of osteoarthritis.

read more

Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images

22 May 2020

In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.

read more

First clinical trial with genetically modified malaria vaccine completed

22 May 2020

In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.

read more

New step in the development of a vaccine against malaria

22 May 2020

A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.

read more